Signs Export Agreement with Australian Pharmaceutical Company
HK inno.N's K-Cab Expands into the Oceania Market
HK inno.N's gastroesophageal reflux disease (GERD) drug, K-Cab, is expanding into the Australian and New Zealand markets.
On the 6th, HK inno.N announced that it has signed a finished product…